Talk To An Expert

+91-95693-30007

Address

Industrial Area Phase 1, Panchkula, Haryana 134113

Email Us

director@sunwinhealthcare.in

Critical Care
Cefprex TZ 312.5

Cefprex TZ 312.5

Ceftriaxone 250 mg+Tazobactum 62.50 mg inj

MRP₹SL
Packaging1S
Form TypeCRITICAL CARE

Ceftriaxone 250 mg + Tazobactam 62.50 mg PCD Pharma Franchise for distributors and wholesalers seeking quality antibiotic products.

Ceftriaxone 250mg + Tazobactam 62.50mg Injection PCD Pharma Franchise

Ceftriaxone 250 mg + Tazobactam 62.50mg Injection is the specialized combination antibiotic formulation that would fit any anti-infective and hospital-based pharmaceutical portfolio for distributors/wholesalers as an effective product for inclusion in to their company catalogs of hospitals, clinics, institutional buyers as well as authorized pharmaceutical trade network dealers. A PCD Pharma Franchise model will enable any distributor/wholesaler to promote pharmaceutical products within defined territory from the company of the Pharma firm. With sterile manufacture, good professional packing, assured supplies, apt documentation as well as suitable business support, the Ceftriaxone 250mg + Tazobactam 62.50 mg Injection PCD Pharma Franchise would make good choice of pharmaceutical business expansion of the company profile.

Ceftriaxone 250mg + Tazobactam 62.50mg Injection PCD Pharma Franchise for Hospital Distribution

The formulation of Ceftriaxone 250 mg + Tazobactam 62.50 mg Injection would complement the anti-infective catalog which includes the hospital segment. Including this formulation among other injectable antibiotic drugs in the product catalog would enable systematic way of making the catalog available to hospitals and pharmacy, clinics and institutional buyers. A distributor/wholesaler can have better supply chain plan, dependable stocks, well-packaged products, right labeling and right batch information.

Ceftriaxone 250mg + Tazobactam 62.50mg Injection PCD Pharma Franchise for Distributor Portfolio Expansion

Expanding product catalog with appropriate range of antibiotics is a useful trend for meeting versatile pharma trade demands of a distributor in defined territory. A product range of injectable antibiotics if taken on PCD Pharma Franchise basis would improve the offering of the distributor's product catalog for use with a PCD Pharma Franchise. Quality as well as sterile practice of manufacture of product, its quantity/ packing, its timely supplies, business and commercial terms available on the franchise, and availability of product all should be assessed before approaching.

Ceftriaxone 250mg + Tazobactam 62.50mg Injection PCD Pharma Franchise for Wholesale Trade Networks

Hospitals, pharmacy, institutional buyers require supply assurance with regard to quantity to be bought under trade practices. Thus, a wholesale marketer dealing at this segment can consider availability of the given drug in their catalog on the PCD Pharma Franchise scheme from the respective manufacturing firm. Stock management, planned dispatches in coordinated manner, necessary documentary proofs and appropriate batch sizes etc are the key aspects for an established wholesale pharma marketer.

Ceftriaxone 250mg + Tazobactam 62.50mg Injection PCD Pharma Franchise for Anti Infective Product Portfolios

Any company engaged in the offering of various kinds of anti infective including injectable antibiotic, cephalosporin type combinations and also hospital based drugs, will likely find that the particular product can indeed fill out a gaps in product range, if this has been done on Ceftriaxone 250 mg + Tazobactam 62.50 mg Injection PCD Pharma Franchise basis. Thus the company will be more focused on a given and particular range while trying to cater to the comprehensive needs of the segment.

Ceftriaxone 250mg + Tazobactam 62.50mg Injection PCD Pharma Franchise for Territory-Based Distribution

A market-wise distributorship with definite segment needs has to identify hospitals with good foot fall, a network of pharmacies as well as wholesalers, which it could cover for sale on territory-based basis with the offer of the said product on PCD Pharma Franchise. Identification of supply needs and ability to meet those in time and consistently can make an excellent reach out of a distributor in a territory.

Ceftriaxone 250mg + Tazobactam 62.50mg Injection PCD Pharma Franchise with Distributor-Oriented Business Support

An arrangement under which such a prescription, injectable antibiotic product could be traded as PCD Pharma Franchise should ideally also be based on favorable business and commercial terms provided to a business partner, which should also cover information relating to the quality assured product made in state-of-the art facility from a reliable supplier having sterile formulation of such powerful antibiotic combo is an optimum business arrangement between two business houses for a gainful venture. If the said pharma firm had other range of hospital antibiotic for distribution in same territory on Pharma franchise it further enhance. Since product as mentioned above, it falls into categories, which are on Prescription so all the marketing plan must be to promote doctor, hospitals along side.

PCD PHARMA FRANCHISE

Start Your Own PCD Pharma Franchise with Monopoly Rights.

  • Complete Product Catalog
  • Net Price List (PDF)
  • Monopoly Area Details

Inquire Now

Fill your details to get an instant callback from our experts.

WHO-GMP Certified

We follow strict quality standards and certified manufacturing processes to ensure safe and effective medicines.

Timely Delivery

We ensure fast and reliable delivery across India to support your business without delays.

Monopoly Rights

Get exclusive monopoly rights in your area to grow your pharma business without competition.

Download Complete Product List

Enter details below to download the PDF instantly.

Start Your Own PCD Pharma Franchise with Monopoly Rights.

  • Complete Product Catalog
  • Net Price List (PDF)
  • Monopoly Area Details

Inquire Now

Fill your details to get an instant callback from our experts.